Nefopam hydrochloride

Research use only, not for human use.

Nefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.

Nefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.(In Vitro):Nefopam hydrochloride (Fenazoxine hydrochloride) is a non-opioid, non-steroidal, centrally acting analgesic drug that is derivative of the non-sedative benzoxazocine. Constitutively elevated β-catenin leads to a delayed and fibrous fracture repair process, and Nefopam inhibits β-catenin mediated signaling during skin wound repair.

Nefopam hydrochloride (Fenazoxine hydrochloride) is a non-opioid, non-steroidal, centrally acting analgesic drug that is derivative of the non-sedative benzoxazocine.Constitutively elevated β-catenin leads to a delayed and fibrous fracture repair process, and Nefopam inhibits β-catenin mediated signaling during skin wound repair.

——

——

Membrane Transporter/Ion Channel

Sodium Channel

Sodium Channel

Neurological Disease

——

23327-57-3

289.8

C17H20ClNO

>98% (HPLC)

Water: 21 mg/mL (72.46 mM); DMSO: 1 mg/mL (3.45 mM)

Cl.CN1CCOC(C2=CC=CC=C2)C2=CC=CC=C2C1

——

(-20℃)

With Ice Pack

≥ 2 years